BioChron is a data-driven technology that increases in vitro fertilization (IVF) success rates by providing personalized recommendations to doctors. It analyzes patient data and returns results within hours to double IVF efficiency compared to average rates. Over 1.5 million IVF cycles are performed annually worldwide but efficiency remains low, with live birth rates typically below 30%; BioChron helps increase the rate to over 60%.

1. BioChron — data-driven technology increasing In Vitro Fertilization success rates

2. One in six couples worldwide
… experience some form of infertility problem
Source: ART Fact Sheet 2014 — ESHRE (EU) November 30, 2015 © Polywed

3. technology has evolved since the year 1978…
November 30, 2015 © Polywed

4. … Efficiency is still low
Average in vitro fertilization live birth rate does not exceed 30%
November 30, 2015 © PolywedSource: Fertility Trends and Figures 2013 — HFEA (UK)
0
5
10
15
20
25
3030

5. Data processing is performed
in the data center
Online form → Data Processing → Personalized recommendations
Doctor fills in the online form
with the patient's data
Result is ready in a few hours
November 30, 2015 © Polywed
b2b: IT service for fertility clinics
Simple 3-step workflow

6. ESHRE
27.0%
SART
29.3%
Polywed
60.2%
average
Sources: ART Fact Sheet 2014 — ESHRE (EU), Clinic Summary Report 2013 — SART (US), Polywed research November 30, 2015 © Polywed
BioChron technology doubles In Vitro Fertilization efficiency
Twofold increase of live birth rate: up to 60.2% avg. per treatment cycle
SART
40.1%
SART
31.4%
SART
21.2%
SART
11.2%
SART
4.5%
Polywed
78.5%
Polywed
64.7%
Polywed
49.6%
Polywed
30.7%
Polywed
11.2%
< 35 years 35 - 37 years 38 - 40 years 41 - 42 years > 42 years

7. 1.5 million ART cycles are performed yearly, producing around 350 000 babies
Global IVF market was valued at $9.3 billion in 2012
and is expected to grow up to $21.6 billion by 2020
 “Global need for ART is estimated to be
at least 1500 cycles/million population
per year”
Dr. Anna Pia Ferraretti,
chairman of ESHRE's
IVF Monitoring Consortium
 The two most active countries
of the world are the USA and Japan,
but the most active region is Europe
EU
590 000
USA + Canada
200 000
Asia-Pacific
330 000
ART cycles per year
Sources: ART Fact Sheet 2014 — ESHRE (EU), Global IVF Market Research 2013 – 2020 — Debbie Shields & Rohini Patil November 30, 2015 © Polywed

8. 1.5 million ART cycles are performed yearly, producing around 350 000 babies
Global IVF market was valued at $9.3 billion in 2012
and is expected to grow up to $21.6 billion by 2020
 “Global need for ART is estimated to be
at least 1500 cycles/million population
per year”
Dr. Anna Pia Ferraretti,
chairman of ESHRE's
IVF Monitoring Consortium
 The two most active countries
of the world are the USA and Japan,
but the most active region is Europe
EU
590 000
USA + Canada
200 000
Asia-Pacific
330 000
ART cycles per year
Sources: ART Fact Sheet 2014 — ESHRE (EU), Global IVF Market Research 2013 – 2020 — Debbie Shields & Rohini Patil November 30, 2015 © Polywed

9. Polywed, LLC
Andrey Temlyakov, CEO
RU: +7 916 243 1857
US: +1 646 583 1857
UK: +44 20 3290 1857
andrey.temlyakov@polywed.com
www.polywed.com
November 30, 2015 © Polywed
BioChron— data-driven technology increasing In Vitro Fertilization success rates
Efficient. High-tech. Reliable.